Status:

RECRUITING

Home Exercise for Individuals with Neurodegenerative Disease

Lead Sponsor:

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Conditions:

Neurodegenerative Diseases

Leukodystrophy

Eligibility:

All Genders

5-75 years

Phase:

NA

Brief Summary

The primary goal of this study is to address the need for targeted therapeutic interventions for impairments that impact walking in related neurodegenerative diseases.

Detailed Description

This study will inform clinicians in quantitatively assessing baseline disease severity, selectively applying the appropriate exercise to the disease pathology, and measuring efficacy of the exercise ...

Eligibility Criteria

Inclusion Criteria:

  • The eligibility criteria for males is X-linked adrenoleukodystrophy as determined by biochemical determination or genetic testing.
  • The eligibility criteria for females is X-linked adrenoleukodystrophy as determined by biochemical determination, genetic testing, or pedigree analysis.
  • The Leukoenceophalopathy with brainstem and spinal cord involvement and lactate elevation inclusion criterion is a confirmed DARS2 mutation through genetic analysis.
  • For people with cerebellar ataxia, people with diagnoses of cerebellar damage from stroke, tumor or degeneration will be included. Those with a genetically confirmed cerebellar disorder will be asked to provide their genetic testing to note their particular type of ataxia.
  • We will also include patients with other neurodegenerative diseases similar to these disorders as determined by chart review and clinical exam.

Healthy Volunteers

  • Able to stand for 30 seconds without upper extremity support
  • Ambulatory (including use of a cane or a walker)
  • Able to walk for 2 minutes

Exclusion Criteria:

  • Other medical or psychological conditions which in the clinical judgement of the investigator would interfere with acquiring the study information or performing the exercises safely including but not limited to:

Uncontrolled hypertension, orthopedic conditions, diabetes, seizure disorder, peripheral vestibular loss, severe aphasia, dementia, pregnancy

Key Trial Info

Start Date :

February 13 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 30 2027

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT05443906

Start Date

February 13 2023

End Date

July 30 2027

Last Update

March 10 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kennedy Krieger Institute

Baltimore, Maryland, United States, 21205

Home Exercise for Individuals with Neurodegenerative Disease | DecenTrialz